Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octagam 10% for severe COVID-19
2020-002482-34Phase 3
- Sponsor
- Octapharma
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Human normal immunoglobulin G in coronavirus disease 2019 (COVID-19), sponsored by Octapharma.
02
Drugs
Human normal immunoglobulin G
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002482-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002482-34.